about
Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing data.Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids.Endoscopic treatment of bronchial carcinoids in comparison to surgical resection: a retrospective study.Unique microRNA-profiles in EGFR-mutated lung adenocarcinomas.Novel molecular tumor cell markers in regional lymph nodes and blood samples from patients undergoing surgery for non-small cell lung cancer.The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma--differences in histological subtypesDetection of disseminated tumor cells in lymph nodes from patients with early stage non-small cell lung cancerIntegrative genome analyses identify key somatic driver mutations of small-cell lung cancerStrategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer.Gender-specific survival after surgical resection for early stage non-small cell lung cancer.[Middle-aged man with fever, hypoxia and bilateral alveolar infiltrates].Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease.Genome-wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis.Trajectories of Symptom Occurrence and Severity From Before Through Five Months After Lung Cancer Surgery.Changes in Symptom Occurrence and Severity Before and After Lung Cancer Surgery.Cause-specific death after surgical resection for early-stage non-small-cell lung cancer.PIK3CA mutations as prognostic factor in squamous cell lung carcinoma.Diagnostic accuracy of computed tomography and histopathology in the diagnosis of usual interstitial pneumonia.EGFR gene alterations in a Norwegian cohort of lung cancer patients selected for surgery.Abstract 1962: Differentially expressed microRNAs in adenocarcinomas of the lung and tumor-adjacent normal lung tissueThe immune microenvironment in non-small cell lung cancer is predictive of prognosis after surgeryIncrease in curative treatment and survival of lung cancer in Norway 2001-2016
P50
Q30887494-2B89B495-1B6F-46C5-855F-E2D89C182475Q34045543-2D93F385-0008-4F70-A79F-627EFB4F9BA5Q34498785-DD7304EC-E790-48AE-82B3-726E8181CA19Q34531091-CA5BDB9F-7F2C-4AD8-870D-6982CAE7527CQ34720505-78B6FDA6-B8C5-4397-8831-FAED1D2BC019Q35917825-DC262F92-FD03-433A-85F3-AD26C16EE78BQ37018090-CFADDCA2-F1EC-405A-8713-3A2FA1A464E9Q38322114-4E869CCC-F878-4C57-BC49-0BEC0019E141Q38636708-EA8D94AC-016C-4A3D-91F9-9AC5AB58641FQ39185876-F610E348-14D3-415A-9C52-705C3655032BQ40459245-4427FB44-CA75-4E3D-BFE7-9E23E3C1CF6EQ40832326-447175A2-7156-478E-94B8-10ED2C9555BAQ41101024-D3D5E640-FE0D-48CD-A304-30760DF2F98CQ46315984-EEC54B5E-9960-45D3-A119-CEF22B6911F3Q46851824-57B59D7E-FB91-4442-BCF2-BD9E8FE837C2Q47260032-CDDECECC-5BB3-4EF0-A447-F6F3F7DF7430Q50988611-8CE4A0A7-5584-4D7B-A93E-D4E0C21F569AQ53175059-5916961C-6CCC-4A19-A9BE-1A843AEA45F6Q54586613-9D93033C-DD63-4B24-87BE-430B93146789Q61051596-3E4D5E76-970E-430B-9FEA-F17B8AB3B740Q64060381-0122BFF0-2B30-4DA0-80D9-6FFE597AD1F5Q91946173-1C2C2C5F-4DBD-490E-B4AE-1A8E11AEC831
P50
description
Noors arts
@nl
Norwegian researcher
@en
norsk forsker og lege
@nb
taighdeoir Ioruach
@ga
name
Steinar Solberg
@ast
Steinar Solberg
@da
Steinar Solberg
@de
Steinar Solberg
@en
Steinar Solberg
@es
Steinar Solberg
@fr
Steinar Solberg
@ga
Steinar Solberg
@nb
Steinar Solberg
@nl
Steinar Solberg
@nn
type
label
Steinar Solberg
@ast
Steinar Solberg
@da
Steinar Solberg
@de
Steinar Solberg
@en
Steinar Solberg
@es
Steinar Solberg
@fr
Steinar Solberg
@ga
Steinar Solberg
@nb
Steinar Solberg
@nl
Steinar Solberg
@nn
prefLabel
Steinar Solberg
@ast
Steinar Solberg
@da
Steinar Solberg
@de
Steinar Solberg
@en
Steinar Solberg
@es
Steinar Solberg
@fr
Steinar Solberg
@ga
Steinar Solberg
@nb
Steinar Solberg
@nl
Steinar Solberg
@nn
P106
P21
P214
250149106376068492916
P2287
P27
P31
P496
0000-0002-8206-5435
P569
1953-01-01T00:00:00Z
P735
P7859
viaf-250149106376068492916